Internal Medicine, Medical Oncology · Fairfax, VA
NPI
1376719906
Since 2008
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8081 Innovation Park Dr
Fairfax, VA, 22031
Phone (571) 472-4724
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
739 services
Medicare patients, 2024
300
Average age 74
Drug cost, 2024
$2.1M
1,107 prescriptions
Company payments, 2025
$2,117
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy L Cannon was code 99215 (office e&m - established), 469 times for 202 patients. In total Timothy L Cannon billed 739 services in 12 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 469 | 202 | $111.85 | $52K |
| 99214 Office E&M - Established | Office | 85 | 74 | $72.27 | $6,143 |
| 99222 Hospital E&M - Initial | Facility | 59 | 54 | $111.42 | $6,574 |
| 99232 Hospital E&M - Subsequent | Facility | 35 | 28 | $67.29 | $2,355 |
| 99205 Office E&M - New | Office | 31 | 31 | $150.85 | $4,676 |
| 99231 Hospital E&M - Subsequent | Facility | 29 | 25 | $42.27 | $1,226 |
| 99213 Office E&M - Established | Office | 14 | 13 | $50.14 | $702 |
By year: 2022 $90K for 1,009 services; 2023 $97K for 900 services; 2024 $76K for 739 services.
Medicare prescription drug claims, 2024
In 2024, the drug Timothy L Cannon prescribed most often to Medicare patients was Eliquis (Apixaban), with 84 prescriptions and refills. In total Timothy L Cannon wrote 1,107 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 84 | 84 | 19 | $45K |
| Ondansetron Hcl Generic | 73 | 75 | 46 | $3,251 |
| Olanzapine Generic | 55 | 78 | 23 | $736 |
| Creon Lipase/Protease/Amylase | 54 | 80 | 14 | $187K |
| Dexamethasone Generic | 48 | 56 | 35 | $675 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 44 | 45 | 37 | $473 |
| Prochlorperazine Maleate Generic | 41 | 42 | 33 | $364 |
| Pantoprazole Sodium Generic | 33 | 68 | 16 | $242 |
| Lonsurf Trifluridine/Tipiracil Hcl | 26 | 26 | Under 11 | $150K |
| Amlodipine Besylate Generic | 25 | 56 | 12 | $173 |
| Celecoxib Generic | 23 | 25 | Under 11 | $378 |
| Famotidine Generic | 21 | 29 | Under 11 | $581 |
| Ondansetron Odt Ondansetron | 21 | 21 | Under 11 | $586 |
| Duloxetine Hcl Generic | 21 | 25 | Under 11 | $560 |
| Gabapentin Generic | 20 | 27 | 11 | $318 |
Brand drugs: - claims; generic drugs: 801 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy L Cannon $2,117 ($2,117 in general payments such as food, travel and fees) from 5 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $2,050.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.